Anika Therapeutics Inc (ANIK): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 23 US Dollar | 1 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 13.382.966 | 3,59 | 3,79 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Anika Therapeutics Inc
Mitarbeiter 235
Handelsplatz NASDAQ
Ticker Symbol ANIK
IPO Datum 1993-04-29
Adresse 32 Wiggins Avenue, Bedford, MA, United States, 01730
Webseite https://www.anika.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Cheryl Renee Blanchard Ph.D. | Executive Chair |
| 2 | Mr. Stephen D. Griffin | President, Principal Financial Officer, CEO & Director |
| 3 | Mr. Ian W. McLeod | Senior VP, Chief Accounting Officer & Treasurer |
| 4 | Mr. Matthew Hall | Executive Director of Corporate Development & Investor Relations |
| 5 | Ms. Lisa Funiciello | VP & Chief Human Resources Officer |
| 6 | Mr. Ben Joseph | Senior Vice President of Commercial |
| 7 | Ms. Mira Leiwant | Senior Vice President of Regulatory, Quality & Clinical Affairs |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 10,83% | 31,59 Mio. USD |
| 2 | Caligan Partners LP | 10,72% | 31,27 Mio. USD |
| 3 | Morgan Stanley - Brokerage Accounts | 4,59% | 13,39 Mio. USD |
| 4 | Acadian Asset Management LLC | 4,53% | 13,22 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 4,27% | 12,47 Mio. USD |
| 6 | AQR Capital Management LLC | 4,18% | 12,20 Mio. USD |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 3,96% | 11,54 Mio. USD |
| 8 | Renaissance Technologies Corp | 3,60% | 10,49 Mio. USD |
| 9 | Dimensional Fund Advisors, Inc. | 3,37% | 9,83 Mio. USD |
| 10 | Capital Management Corp | 3,35% | 9,77 Mio. USD |
| 11 | Deutsche Bank AG | 2,64% | 7,70 Mio. USD |
| 12 | Geode Capital Management, LLC | 2,48% | 7,23 Mio. USD |
| 13 | State Street Corp | 2,33% | 6,80 Mio. USD |
| 14 | Two Sigma Investments LLC | 1,89% | 5,51 Mio. USD |
| 15 | D. E. Shaw & Co LP | 1,83% | 5,34 Mio. USD |
| 16 | The Goldman Sachs Group Inc | 1,78% | 5,18 Mio. USD |
| 17 | Jacobs Levy Equity Management, Inc. | 1,63% | 4,74 Mio. USD |
| 18 | Nuveen, LLC | 1,17% | 3,41 Mio. USD |
| 19 | Quantinno Capital Management LP | 1,16% | 3,38 Mio. USD |
| 20 | UBS Group AG | 1,09% | 3,18 Mio. USD |